Plain-English translation of NCT07779057 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing as a way to prevent preeclampsia—a serious condition that can develop during pregnancy and harm both mother and baby. Researchers want to know whether taking 150 mg of daily works better than taking 75 mg daily at preventing this condition in pregnant women who are already at high risk. The study will also look at how the two doses affect newborn birth weight and stillbirth rates.
Preeclampsia is a dangerous pregnancy complication that can threaten the health of both mother and baby. Low-dose is already used to help prevent it, but doctors aren't sure if a slightly higher dose might work even better. This study aims to find the most effective dose to protect high-risk pregnancies.
You likely qualify if…
You likely don't qualify if…
You would take one tablet by mouth every evening at bedtime, starting at 11-14 weeks of pregnancy and continuing until 36 weeks. You'll visit your doctor every two weeks to check how you're doing and whether preeclampsia has developed. After your baby is born, the medical team will measure your newborn's weight and continue watching for any complications. The entire study lasts from your enrollment through delivery.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
Pakistan